EAM Investors’s DNA X Inc SONM Stock Holding History

EAM Investors’s Portfolio SONM Stock Details SONM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,671	Closed	-$1.17M	–	372
2023 Q2	$1.17M	Buy	+5,671	New	+$1.11M	0.22%	209
2019 Q3	–	Sell	-63	Closed	-$1.44M	–	292
2019 Q2	$1.44M	Buy	+63	New	+$1.6M	0.35%	135

Other funds holding SONM

Sicart Associates New York $389M AUM 42.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FFA

First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

EAM Investors's SONM Position: Q3 2023 in Review

EAM Investors sold out of DNA X Inc (SONM) in Q3 2023, closing a stake of 5,671 shares — an estimated $1.17M sold.

EAM Investors first reported a position in SONM in Q2 2019 and held it in 2 quarters. The position peaked at $1.44M in Q2 2019. 16 funds tracked by Wall St. Rank hold SONM as of Q3 2023.

EAM Investors reported no remaining DNA X Inc position as of Q3 2023 after selling out during the quarter.
EAM Investors sold 5,671 DNA X Inc shares in Q3 2023, an estimated $1.17M.
EAM Investors first reported a position in DNA X Inc in Q2 2019 and held it in 2 quarters.
EAM Investors's DNA X Inc position peaked at $1.44M in Q2 2019.
16 funds tracked by Wall St. Rank held DNA X Inc as of Q3 2023.

Based on EAM Investors's 13F filing for Q3 2023, filed 13 Nov 2023.